Skip to main content
Log in

Add-on omalizumab improves QOL in severe allergic asthma

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Chipps B, Buhl R, Beeh K-M, Fox H, Thomas K, Reisner C.Improvement in quality of life with omalizumab in patients with severe allergic asthma. Current Medical Research and Opinion 22: 2201-2208, No. 11, Nov 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Add-on omalizumab improves QOL in severe allergic asthma. Pharmacoecon. Outcomes News 518, 9 (2006). https://doi.org/10.2165/00151234-200605180-00030

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605180-00030

Keywords

Navigation